News

• Debevoise Makes Significant Investments in Restructuring Capabilities with Partner Hires and Leadership Appointments
  12 February 2026
• Debevoise Advised White Cap, a CD&R Portfolio Company, in Its Acquisition of Colony Hardware
  9 February 2026
• Debevoise Advises Elara Caring in Strategic Investment from Ares and DaVita
  4 February 2026
• Debevoise Advises Arctic Glacier, a Carlyle Portfolio Company, in Its Sale to Reddy Ice
  2 February 2026
• Debevoise Advised SunSource, a CD&R Portfolio Company, in Its Acquisition of Vytl Controls Group
  30 January 2026
• Debevoise Advises HarbourVest in Its Structured Solutions Vehicle For Private Market Secondaries
  27 January 2026
• Debevoise Advises AIG in Its Strategic Partnership with CVC
  26 January 2026
• Debevoise Advises Ares as Co-Lead Investor in Connection with Bansk Continuation Fund Transaction
  22 January 2026
• Debevoise Advised Elliott in Connection with Its Investment in Stratolaunch
  20 January 2026
• Debevoise Advised KKR in the Formation of Its $2.5 Billion Asia Private Credit Fundraise
  20 January 2026
• Debevoise Advised Portage in Its Acquisition of Select Assets of Point72 Ventures’ Fintech Portfolio
  15 January 2026
• Debevoise Advised Canaccord Genuity in Its Acquisition of Carbon Reduction Capital
  14 January 2026
• Debevoise Advises CRC Group in Its Acquisition of Euclid Transactional
  7 January 2026
• Debevoise Advises TPG in Its Long-Term Strategic Investment Management Partnership with Jackson Financial, Including a Minimum Commitment of $12 Billion of AUM and $500 Million Minority Investment
  7 January 2026
• Debevoise Advises Easy Solar and Azimuth in Cross-Border Refinancing
  6 January 2026
• Debevoise Names Seven New Counsel
  6 January 2026
• Debevoise Advises an Investor Group Led by Trian and General Catalyst in the $7.4 Billion Acquisition of Janus Henderson Group
  22 December 2025
• Debevoise Advises Vantage in Its $2.1 Billion Sale to Howard Hughes
  18 December 2025
• Debevoise Advises TPG and OneOncology in the Sale of TPG’s Equity Interest in OneOncology to Cencora at an Enterprise Value of $7.4 Billion
  16 December 2025
• Debevoise Advised Manulife in Its $1 Billion U.S. Offering of 4.986% Senior Notes due 2035
  11 December 2025
• Debevoise Advises Warner Bros. Discovery in Its Sale to Netflix at an Enterprise Value of $82.7 Billion
  5 December 2025